We have investigated if fentanyl protects against myocardial ischaemic injury and if so, if the mechanism of this protection is mediated via opioid and adenosine A 1 receptors, and K ATP channels. Langendorff rat hearts were subjected to global ischaemia (30 min) and reperfusion (60 min). The drugs were administered before induction of ischaemia and maintained throughout the experiment. Treatment with fentanyl 740 nmol litre -1 improved post-ischaemic mechanical function, assessed as developed pressure, ϩdP/dtmax and -dP/dtmin, compared with controls after 60 min of reperfusion. These effects were abolished by naloxone 1 µmol litre -1 , DPCPX 10 µmol litre -1 , a selective adenosine A 1 antagonist and sodium 5-hydroxydecanoate 100 µmol litre -1 , a K ϩ ATP channel blocker. We conclude that fentanyl protected the heart against post-ischaemic injury by a mechanism which was blocked by an opioid and an adenosine A 1 receptor antagonist and also by a K ATP channel antagonist.
Transient myocardial ischaemia may occur during
Opioids are linked to PKC [8] [9] [10] and are therefore putative mediators in preconditioning. 6 7 10 Indeed, opioid receptor anaesthesia and surgery. Myocardial performance is compromised to a variable degree after ischaemia and subsequent agonists have been shown to protect the heart from the insult of ischaemia. Administration of morphine before an reperfusion. This dysfunction reflects either irreversible (infarction) or reversible injury. The latter is often termed ischaemic insult mimics ischaemic preconditioning and protects against infarction in anaesthetized rats 11 12 and in myocardial stunning where dysfunction persists despite return of full perfusion. Recovery of this dysfunction is isolated rat hearts. 13 Furthermore, the opioid antagonist naloxone abolishes ischaemic preconditioning. 14 15 Howfacilitated by some drugs, including halogenated anaesthetics. [1] [2] [3] [4] In many models investigating this improvement, ever, there has been little work on the protective effects which activation of the opioid system may confer against the protective drug is given before the ischaemic insult and, therefore, may act by preconditioning. This term was origin-contractile dysfunction which occurs after brief periods of ischaemia. ally coined for the protection which brief periods of ischaemia confer on the heart against subsequent damage Adenosine is released endogenously from the myocardium during ischaemia and reperfusion, and alleviates caused by prolonged ischaemia. 5 This phenomenon, 'ischaemic' preconditioning, has been investigated exten-ischaemic damage. 16 Exogenous adenosine receptor agonists have been shown to protect against injury in various sively because of its clinical relevance and scientific interest. Several mediators are involved in myocardial precondi-myocardial ischaemia models. 3 17 18 Several mechanisms have been postulated for their protective action, including tioning, including protein kinase C (PKC) and ATP-sensitive potassium channels (K ATP channels). 6 7 The existence of inhibition of norepinephrine release from sympathetic nerve endings and attenuation of production of free radicals and mediators has suggested the possibility for novel interventions which would represent 'pharmacological' precondi-calcium influx into reperfused myocardium. 19 20 There is convincing evidence to suggest involvement of adenosine tioning; protection could be induced by administering drugs which activate effectors intervening in ischaemic pre-receptors in ischaemic preconditioning. Adenosine A 1 receptors share with opioid receptors a common cellular pathway conditioning before the ischaemic period, and serve the same purpose as brief ischaemic episodes.
linked to PKC, 21 and an adenosine A 1 blocker abolishes the cardiac protection induced by ischaemic precondi-Medical Inc, Lancashire, UK). All hearts were paced with right ventricular epicardial electrodes at a fixed rate of 5 Hz tioning. 22 23 Furthermore, protective effects by activating α 1 adrenergic receptors, equivalent to opioid receptors in (2 ms, 5 V square pulses). The volume of the balloon was adjusted to achieve an end-diastolic pressure (EDP) of the PKC activation pathway, 6 7 have been blocked by an adenosine A 1 antagonist, 24 25 suggesting that adenosine may 5-10 mm Hg which remained unchanged throughout the study. be a key effector in pharmacologically induced preconditioning.
After a stabilization period of 10 min, only those hearts that met the following criteria were studied: peak systolic K ATP channels are activated as a result of a decrease in the level of intracellular ATP, and are well characterized in pressure (PSP) Ͼ85 mm Hg; EDP Ͻ10 mm Hg; and coronary flow (CF) Ͼ12.0 ml min -1 . myocytes. 26 Although the role of enhancement of K ϩ conductance in the progression of ischaemic damage
Experimental design
remains unknown, activation of this channel is without doubt involved in the protection against myocardial isch-Hearts were allocated to one of 18 groups. aemic injury. Opening of this channel has been shown Non-ischaemia study repeatedly to facilitate recovery of mechanical function 27 28 There were six groups in this study. The hearts in these and decrease infarct size after ischaemia. 29 The well known groups did not undergo ischaemia. Group NI-Fent was protection exerted by halogenated anaesthetics against treated with fentanyl (nϭ5), group NI-Nal with the nonstunning is mediated by activation of K ATP channels. 30 31 selective opioid receptor antagonist naloxone (nϭ5), group Of further interest is the fact that PKC activates K ATP NI-HD with the K ATP channel blocker sodium 5-hydroxychannels. 32 These channels are regarded as the end-effector decanoate (5-HD) (nϭ5), group NI-Veh with the vehicle in ischaemic preconditioning. 6 7 dimethyl sulphoxide (DMSO) (nϭ5), group NI-DPC with The purpose of this study was to examine if administration the adenosine A 1 antagonist 1,3-depropyl-8-cyclopentylxanof fentanyl protects against post-ischaemic mechanical dysthine (DPCPX) (nϭ5) and group NI-Cont with no drug. function, and if protection was evident, to determine if an opioid receptor antagonist, an A 1 adenosine receptor Ischaemia study 1 antagonist or a K ATP channel blocker could prevent this There were 10 groups according to which drug(s) was protection. Fentanyl was chosen because it is used widely administered. Group Fent was treated with fentanyl (nϭ7), in clinical practice, including the management of patients group Nal with naloxone (nϭ6), group HD with 5-HD with ischaemic heart disease, and its protective potential (nϭ5), group Veh with DMSO (nϭ6), group DPC with has not been investigated. DPCPX (nϭ6), group FentϩNal with fentanyl and naloxone (nϭ7), group FentϩHD with fentanyl and 5-HD (nϭ5), group FentϩVeh with fentanyl and DMSO (nϭ5) and group
Materials and methods
FentϩDPC with fentanyl and DPCPX (nϭ6). The control The study was performed in accordance with the UK group (Cont) (nϭ8) received no drug treatment. Animal Act (scientific procedures) 1986 (Home Office licence number 30/00980).
Ischaemia study 2
The hearts were allocated to one of two groups depending
Preparation of rat hearts
on the period of fentanyl incubation before ischaemia. Group Fent10 (nϭ7) was perfused with fentanyl for 10 min Adult male Wistar rats (325-400 g) were anaesthetized with pentobarbital 60 mg kg -1 i.p. The hearts were excised and group Fent15 (nϭ6) for 15 min. rapidly, arrested in ice-cooled Krebs-Henseleit buffer, and perfused retrogradely through the aorta using a Langendorff
Concentrations of the drugs were fentanyl 740 nmol litre -1 (Janssen-Cilag Ltd, Buckinghamshire, UK), naloxone apparatus. The Krebs-Henseleit perfusion solution (containing (mmol litre -1 ) NaCl 118.7, KCl 4.7, MgSO 4 1.2, 1 µmol litre -1 (Du Pont Pharmaceuticals Ltd, Hertfordshire, UK), 5-HD 100 µmol litre -1 (Sigma-Aldrich, Dorset, UK) KH 2 PO 4 0.95, NaHCO 3 28, CaCl 2 1.3 and glucose 10) was filtered through a 5.0 µm filter, oxygenated with a mixture and DPCPX 10 µmol litre -1 (Sigma-Aldrich) (in 0.04% DMSO (Sigma-Aldrich)). of 95% oxygen and 5% carbon dioxide, and maintained at 37°C throughout the procedure. pH was 7.4 when The experimental procedure is summarized in Figure 1 . After a period of stabilization (10 min), pre-drug levels equilibrated with carbon dioxide at 37°C. Perfusion pressure was set at 100 cm H 2 O and kept constant.
of ventricular mechanical function were measured. The appropriate drug was then administered to the perfusate and The left and right ventricles were vented by apical puncture with a polyethylene drain and ventriculotomy, maintained until the end of the study. In the non-ischaemia study, measurements were obtained at 20, 60, 70, 80, 90, respectively. A latex balloon, slightly larger than the ventricle, was inserted through the left atrium into the left 100 and 110 min after administration of 5-HD in group NI-HD, and at 15, 55, 65, 75, 85, 95 and 105 min after the ventricle and connected by a polyethylene catheter to a saline-filled syringe and to a pressure transducer (Medex pre-drug measurement in the remainder of the non-ischaemia groups. 5-HD had a longer pre-treatment time so that the antagonists. This was because preliminary experiments showed that the effect of fentanyl was not blocked by 5-HD results from the non-ischaemia study were comparable with ischaemia study 1 where 5-HD needed an additional 5 min with 5 min pre-incubation (data not shown).
Measurements included PSP, EDP, developed pressure pre-incubation time (see below). In the ischaemia studies, measurements just before ischaemia were taken as pre-(DP), maximum positive and minimum negative left ventricular pressure derivatives (ϩdP/dtmax and -dP/dtmin) ischaemic values. Ischaemia was caused by stopping the flow of the perfusate to the heart, and pacing was stopped and CF. at the onset of ischaemia. After 30 min of ischaemia, aortic
Data collection and analysis
flow was reintroduced and continued for a further period of 60 min. Pacing was reintroduced 8 min into reperfusion Left ventricular pressure was monitored continuously throughout the experiment. The left ventricular pressure and continued until the end of the study. Measurements were obtained at 10, 20, 30, 40, 50 and 60 min during signal was digitized at 250 Hz (analogue-digital converter AT-MIO, National Instruments Corporation, TX, USA) and reperfusion. 5-HD was pre-incubated for 10 min before administration of fentanyl, 5 min longer than the other stored on the hard disk of a desktop computer. Data were Table 1 Indices of mechanical function in the non-ischaemia study. Times in [ ] were used only in group NI-HD. DPϭDeveloped pressure; EDPϭend-diastolic pressure; ϩdP/dtmaxϭmaximum positive left ventricular pressure derivative; -dP/dtminϭminimum negative left ventricular pressure derivative; CFϭcoronary flow. NIϭNon-ischaemic; Contϭcontrol (no drug); Fentϭfentanyl; Nalϭnaloxone; HDϭ5-HD. Results are mean (SEM). No differences between groups at any time collected and processed using data acquisition and analysis Results software developed in our department.
Non-ischaemia study
PSP and EDP were averaged values computed respectively from 10-14 heart beats. DP was defined as the The mechanical indices in the non-ischaemic groups are difference between PSP and EDP. ϩdP/dtmax and -dP/ shown in Table 1 . There were no significant differences dtmin were obtained by differentiation of the ventricular between groups throughout the study. pressure signal. These were also averaged values from 10-Ischaemia study 1 14 heart beats. EDP was defined as the pressure at the first positive deflection of the left ventricular dP/dt signal.
Figures 2 and 3 show changes in DP and -dP/dtmin in groups Cont, Fent, Nal and FentϩNal. There were no
Statistical analysis significant differences between groups during the preischaemic period. At the end of reperfusion (60 min), group All values are expressed as mean (SEM). Differences in indices between groups at various times were compared Fent had a significantly higher DP (58 (3) mm Hg) than all other groups (group Cont 34 (5), group Nal 40 (4) and using two-way analysis of variance (ANOVA) for treatment and time with repeated measures on a time factor. If group FentϩNal 37 (7) mm Hg) (PϽ0.01). A similar result was obtained for -dP/dtmin, which was also greater in ANOVA indicated significant differences between groups, further comparisons on specific times were performed using group Fent (943 (34) mm Hg s -1 ) compared with the other groups (group Cont 578 (83), group Nal 659 (75) and group Fisher's test. Statistical significance was assumed at PϽ0.05.
(PϽ0.05), ϩdP/dtmax (PϽ0.05) and -dP/dtmin (PϽ0.01) in group Fent were significantly greater at the end of reperfusion than in all other groups. There were no significant differences in EDP and CF between groups at any time.
Figures 6 and 7 and Table 3 show the changes in indices of mechanical function in groups Veh, FentϩVeh, DPC and FentϩDPC. Groups Veh, DPC and FentϩDPC showed similar recovery profiles for DP (Fig. 6) , ϩdP/dtmax (Table  3) and -dP/dtmin (Fig. 7) . DP in group FentϩVeh was significantly greater at the end of reperfusion than in all other groups (group FentϩVeh 59 (5), group Veh 37 (5), group DPC 33 (7) and group FentϩDPC 33 (5) mm Hg) (PϽ0.01). ϩdP/dtmax and -dP/dtmin were also greater in group FentϩVeh compared with the other groups at the end of reperfusion (PϽ0.01). There was no significant difference in EDP or CF between groups at any time. There were no differences between groups during the preischaemia in groups Cont, Fent, Nal and FentϩNal (ischaemia study 1 No difference was found between groups Fent10 and Fent15 for any index at any time (Table 4 ). The recovery profiles of DP, ϩdP/dtmax, -dP/dtmin and EDP in groups Fent10 and Fent15 were similar to those in group Fent.
Discussion
The non-ischaemia study showed that none of the drugs had any effect on the mechanical function of the nonischaemic heart. It is clear from ischaemia study 1 that fentanyl protected the ischaemic myocardium, enhancing both post-ischaemic systolic (DP and ϩdP/dtmax) and diastolic (-dP/dtmin) function. Furthermore, ischaemia study 1 suggests that this protection may be blocked by naloxone, 5-HD and DPCPX, as the recovery profiles of mechanical function after ischaemia were similar between groups Nal and FentϩNal, groups HD and FentϩHD, and groups DPC and FentϩDPC. However, group Fent was not and 5 min shorter in group Fent. Therefore, we performed ischaemic study 2 to show that the difference in the preincubation time with fentanyl did not cause any difference FentϩNal 588 (117) mm Hg s -1 ) (PϽ0.01) at 60 min reperfusion. Table 2 shows the changes in the other indices in the recovery of mechanical function and, therefore, the extent of protection. Our studies demonstrated that the of mechanical function in groups Cont, Fent, Nal and FentϩNal. ϩdP/dtmax showed similar recovery to DP protective effect of fentanyl was blocked by addition of an opioid receptor antagonist, an adenosine A 1 receptor and -dP/dtmin. There were no significant differences between groups for EDP or CF.
antagonist or the K ATP channel blocker. Table 2 show the indices of mechanical function in groups Cont, Fent, HD and an opioid has not been reported previously, studies showed that morphine protected against infarction in an in vivo 11 12 FentϩHD. DP (Fig. 4) , ϩdP/dtmax (Table 2) and -dP/ dtmin (Fig. 5) showed similar recovery profiles in groups and an in vitro rat model. 13 This effect was blocked by naloxone and a K ATP channel blocker glibenclamide. 11 Cont, HD and FentϩHD. There were no significant differences between groups before the ischaemic period. DP Although fentanyl is preferentially a µ opioid receptor agonist, it is capable of binding to δ and κ receptors. 33 Of opioid and an adenosine A 1 receptor antagonist block such protective effects are unknown. One hypothesis is based on the several known subtypes of opioid receptor agonists, δ opioid agonists have been shown to provide protection the PKC model of pharmacologically induced preconditioning. Activation of PKC in the myocyte has been against ischaemic injury. Schultz and colleagues reported that a δ 1 opioid receptor agonist decreased infarct size in suggested to be the key event in the process of protection. 6 7 Stimulation of PKC-linked receptors by α 1 adrenergic an in vivo rat model after 30 min of regional ischaemia 34 and that δ, but not µ or κ, opioid antagonists eliminated agonists, 41 42 endothelin-1 43 44 and bradykinin 4 45 has been shown to induce protective effects via PKC activation. the protection conferred by morphine in anaesthetized rats. 35 In contrast, κ agonists appeared to enhance cardiac δ-Opioid receptor agonists also enhance PKC activity via G proteins in the myocyte. 8 9 Furthermore, a PKC antagonist ischaemic injury. Indeed, dynorphin, a κ agonist, decreased ventricular mechanical function in vivo in rats, 36 and was has been reported to inhibit morphine-induced preconditioning in the isolated heart preparation. 13 Although arrhythmogenic in both in vitro 37 and in vivo 38 rat ischaemia models. δ and κ opioid receptors have been characterized involvement of either G proteins or PKC was not examined in our study, PKC activation is a possible explanation for in the rat heart, 39 40 but the existence of µ opioid receptors is doubtful. It has been reported that µ opioid receptors are the protective characteristics of fentanyl. In common with α 1 adrenergic, bradykinin and δ opioid receptors, A 1 adenosine not expressed in the whole heart 39 or in isolated myocytes 40 of rats.
While protection against post-ischaemic dysfunction by Figures 4 and 5 and
receptors have been reported to activate PKC via G proteins in the myocyte. 21 Pretreatment with A 1 adenosine receptor The cellular mechanisms by which fentanyl exerts its postischaemic protective action, and the mechanisms whereby an agonists protected the heart against ischaemic injury 17 and this protection was eliminated by PKC block. 46 Downey addition of either opioid or adenosine A 1 antagonists reduces the activity of PKC below the threshold, abolishing its and Cohen have suggested that myocardial protection is obtained by the combined activities of several types of protective action.
An alternative hypothesis to explain the protection receptors, all acting via the PKC pathway. 6 According to their model, protection is achieved only if the activity of provided fentanyl and the ability of two different types of receptor antagonists to abolish it, is that of an indirect PKC exceeds a threshold level. Our results are consistent with such a model, where there were at least two sources mechanism. For example, the interaction of fentanyl with opioid receptors could result in release of adenosine, which for stimulation of PKC: fentanyl acting at the δ opioid receptor which was added to the perfusate, and adenosine in turn acts on adenosine A 1 receptors to induce a protective effect. There is some evidence for such an indirect action released during ischaemia. 16 For protection to occur, the combined effects of these two agonists must increase the in the spinal cord, where µ and δ opioid receptors have been shown to mediate adenosine release from synaptoactivity of PKC above threshold. Hence removing one by somes. 47 By extrapolation from the central nervous system, our study, the heart was perfused with fentanyl not only during the pre-ischaemic period but also during reperfusion. such release could be thought to occur in the heart. Adenosine release can induce pharmacological precondi-Therefore, fentanyl could have exerted its protective effect during reperfusion by a mechanism independent of preconditioning via PKC, as mentioned above, and may also offer protection via other mechanisms, such as attenuation of tioning.
There is much speculation that K ATP channels may be production of oxygen-derived free radicals and calcium influx into the myocardium on reperfusion. 19 20 Indeed, in the end-effector of myocardial protection. Addition of K ATP channel openers results in ischaemic preconditioning of the patients with ischaemic heart disease who may suffer from heart. 27-29 Furthermore, the protection produced by PKC-myocardial ischaemia during anaesthesia and surgery. linked receptor agonists, such as adenosine 22 and endoIn summary, the results of our study suggest that thelin-1, 44 is blocked by K ATP channel blockers. Hence it fentanyl, an opioid agonist, enhanced the recovery of has been proposed that activation of PKC results in the cardiac mechanical function after ischaemia via an unknown opening of K ATP channels which produce myocardial mechanism involving opioid and A 1 adenosine receptors, protection. 32 48 49 There is little evidence of a direct link and K ATP channels. We are currently undertaking further between opioid receptors and K ATP channels in the myo-studies to investigate the cellular mechanisms by which cardium, although the actions of a δ opioid agonist are fentanyl exerts this protective effect, in particular whether abolished by a K ATP channel blocker in the vascular 50 and PKC is involved, and whether the protection affects the central nervous 51 systems.
extent of infarction and/or the degree of stunning. ElucidaIn our study, variables of mechanical function were used tion of the mechanisms of opioid-mediated protection could to examine the extent of ischaemic damage resulting from pave the way for the development of interventions reducing 30 min of global ischaemia. We cannot determine if myocardial ischaemic injury in clinical practice. improved recovery was caused by more limited irreversible injury (infarction), reduced degree of reversible damage
